LiteVax BV is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel immunoadjuvants to increase vaccine efficacy. New and more effective vaccines against a wide range of infectious diseases are needed as evidenced by the recent outbreaks.
| Website | http://www.litevax.com |
| Revenue | $202000 |
| Employees | View employees |
| Address | 63 Industrielaan, Oss, North Brabant, NL |
| Phone | +31 6 12029451 |
| Industry | Business Services General, Business Services |
| Competitors | CureVac, Moderna Therapeutics, Pfizer, GSK, Novavax, Sanofi, AstraZeneca, Merck & Co., Inc., Johnson & Johnson, Vaxart, Inc. +35 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies |
Looking for a particular Litevax B.V. employee's phone or email?
Litevax B.V. Questions
The Litevax B.V. annual revenue was $202000 in 2026.
Litevax B.V. is based in Oss, North Brabant.
The NAICS codes for Litevax B.V. are [54, 54171, 5417, 541713, 541].
The SIC codes for Litevax B.V. are [873, 87].
G2Crowd Trusted
300K+
Plugin Users
